Effect of montelukast on nuclear factor κB activation and proinflammatory molecules

This publication has 23 references indexed in Scilit:

• Significant Involvement of CCL2 (MCP-1) in Inflammatory Disorders of the Lung
  Microcirculation, 2003
• Expression of the Cysteinyl Leukotriene 1 Receptor in Normal Human Lung and Peripheral Blood Leukocytes
  American Journal of Respiratory and Critical Care Medicine, 2001
• Clarithromycin Inhibits NF-κB Activation in Human Peripheral Blood Mononuclear Cells and Pulmonary Epithelial Cells
  Antimicrobial Agents and Chemotherapy, 2001
• Nuclear factor k B: a pivotal role in the systemic inflammatory response syndrome and new target for therapy
  Intensive Care Medicine, 1998
• Role of IL-6 and Its Soluble Receptor in Induction of Chemokines and Leukocyte Recruitment
  Published by Elsevier ,1997
• THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
  Annual Review of Immunology, 1996
• Control of IκB-α Proteolysis by Site-Specific, Signal-Induced Phosphorylation
  Science, 1995
• Pharmacology of montelukast sodium (Singulair™), a potent and selective leukotriene D₄receptor antagonist
  Canadian Journal of Physiology and Pharmacology, 1995
• Function and Activation of NF-kappaB in the Immune System
  Annual Review of Immunology, 1994
• Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8.
  Proceedings of the National Academy of Sciences, 1993